Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,361 public trials 354 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

NCT00879658

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +16 more
Locations
  • Novartis Investigative Site Cullman, Alabama, United States
  • Novartis Investigative Site San Francisco, California, United States
  • Novartis Investigative Site Centennial, Colorado, United States
  • Novartis Investigative Site Miami, Florida, United States
View all 72 locations
View Trial Details
Completed

Biomarkers in Multiple Sclerosis

NCT00325988

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse

NCT02633033

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Alabama Neurology Associates Homewood, Alabama, United States
  • Territory Neurology & Research Institute Tucson, Arizona, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
  • Advanced Neurosciences Research Fort Collins, Colorado, United States
View all 38 locations
View Trial Details
Completed

Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial

NCT01962571

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +8 more
Locations
  • Medical Center - University of Freiburg, Eye Hospital Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Heidelberg University Hospital, Department of Neurooncology Heidelberg, Baden-Wurttemberg, Germany
  • Tuebingen University Hospital Tübingen, Baden-Wurttemberg, Germany
  • University Hospital Erlangen Erlangen, Bavaria, Germany
View Trial Details

Related conditions